awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38936104-B4474F6F-5360-428E-B22D-3F477246B7DE
Q38936104-B4474F6F-5360-428E-B22D-3F477246B7DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38936104-B4474F6F-5360-428E-B22D-3F477246B7DE
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
P2860
Q38936104-B4474F6F-5360-428E-B22D-3F477246B7DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38936104-B4474F6F-5360-428E-B22D-3F477246B7DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf4f4d52248a00e30dd4056751d8b1e71fdc75c5
P2860
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors.